CD79A and breast cancer: Indirect evidence to support BC for protection against NEC comes from studies showing that BC contains IgG and IgA antibodies directed against pathogens that have been associated with NEC, such as Klebsiella, Citrobacter, Enterobacter, and Serratia [210].